Lilly plans to invest $1.6bn in Indiana manufacturing facilities
Pharmaceutical Technology
APRIL 18, 2023
The new facilities will also support the company’s efforts to manufacture new therapeutic modalities, including genetic medicines. The company has launched 19 new medicines since 2014, including Jaypirca, which was approved by the US Food and Drug Administration in January 2023 to treat mantle cell lymphoma.
Let's personalize your content